GlassScriptPhysician profile
Alejandro Lemor Ferrand
NPI 1295120673
$36,590.79
in general payments reported to CMS, 2019-2025
34 companies · $5,316 in 2025
The $5,316 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $51.15 · 2022: $19K · 2023: $7,312 · 2024: $4,874 · 2025: $5,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Honoraria: $2,750 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,750 · Consulting Fee: $1,100 · Travel and Lodging: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,043.05 |
| Honoraria | $2,750.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,750.00 |
| Consulting Fee | $1,100.00 |
| Travel and Lodging | $859.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $27,013.81 | 2022-2025 | Impella |
| Shockwave Medical, INC | $4,416.15 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $639.43 | 2025 | Manta, Guideliner |
| Livanova USA, INC. | $597.75 | 2022-2023 | Lifesparc |
| Boston Scientific Corporation | $487.30 | 2019-2025 | Watchman Access System, Avvigo Guidance System |
| Inari Medical, INC. | $349.07 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $331.72 | 2022-2025 | Lm Undivided |
| Stryker Corporation | $264.52 | 2025 | Clottriever Bold Catheter, Artix Mt, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.45 | 2023-2025 | Jardiance |
| Penumbra, INC. | $218.30 | 2025 | Indigo System |
| Medtronic, INC. | $198.41 | 2024-2025 | Symplicity G3, Hawkone, In.Pact Admiral |
| Astrazeneca Pharmaceuticals LP | $187.33 | 2022-2024 | Wainua, Brilinta |
| Alnylam Pharmaceuticals INC. | $164.48 | 2025 | Amvuttra |
| Pfizer INC. | $135.83 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.01 | 2023-2025 | Camzyos, Eliquis |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $128.41 | 2022-2025 | |
| Cardiva Medical, INC. | $114.28 | 2024-2025 | Cardiva Vascade 6/7f Vcs |
| Amgen INC. | $108.06 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $103.61 | 2022-2023 | Optimizer |
| Edwards Lifesciences Corporation | $92.79 | 2022-2024 | Sapien 3 Ultra Resilia |
| Cordis US Corp. | $92.21 | 2025 | Mynx Control Venous |
| Merck Sharp & Dohme LLC | $78.10 | 2022-2024 | Verquvo |
| Procyrion, INC. | $75.10 | 2024-2025 | Aortix System |
| Actelion Pharmaceuticals US, INC. | $57.95 | 2022-2025 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $54.66 | 2022-2023 | Xarelto |
| Angiodynamics, INC. | $53.47 | 2023 | Angiovac |
| Imperative Care, INC | $53.18 | 2025 | Symphony Catheter |
| Abbott Laboratories | $48.96 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Bridgebio Pharma, INC. | $41.25 | 2025 | Attruby |
| Terumo Medical Corporation | $24.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.85 | 2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.00 | 2022 | |
| Irhythm Technologies, INC. | $16.96 | 2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $16.55 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Lemor Ferrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.